AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19745649 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (80 mg/d)
Number of subjects: 20
Study 19745649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 17326089 — intervention group
Group type: EXPERIMENTAL
Intervention: R2* imaging at 3T
Number of subjects: 34
Study 17326089 — intervention group
Group type: COMPARATOR
Intervention: R2* imaging at 1.5T
Number of subjects: 34
Study 17326089 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined R2* data from patients and control subjects
Number of subjects: 34
Study 17326089 — intervention group
Group type: EXPERIMENTAL
Intervention: R2* imaging at 3T vs 1.5T in the liver
Number of subjects: 34
Study 17326089 — intervention group
Group type: EXPERIMENTAL
Intervention: R2* imaging at 3T vs 1.5T in the heart
Number of subjects: 34
Study 15029544 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia with morphine (PCA)
Number of subjects: 45
Study 15029544 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoas compartment block (PCB)
Number of subjects: 45
Study 15029544 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block (FNB)
Number of subjects: 45
Study 15029544 — intervention group
Group type: COMPARATOR
Intervention: All groups (PCA, FNB, PCB)
Number of subjects: 45
Study 11125723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 139
Study 11125723 — intervention group
Group type: COMPARATOR
Intervention: Self-Monitoring Control (SMC)
Number of subjects: 139
Study 11125723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy Deferred (CBT-DEF)
Number of subjects: 139
Study 11125723 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT
Number of subjects: 139
Study 9639078 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 4
Study 9639078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 8079104 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole daily at 0800 h (group A)
Number of subjects: 20
Study 8079104 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole every other day (group B)
Number of subjects: 20
Study 8079104 — intervention group
Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 20
Study 2788085 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised bicycle training programme three times a week for 12 weeks starting 6 weeks after surgery
Number of subjects: 37
Study 2788085 — intervention group
Group type: COMPARATOR
Intervention: Non-training group
Number of subjects: 37
Study 2788085 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 37
Study 178243 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg glucagon intramuscularly
Number of subjects: 60
Study 178243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31904670 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychoeducational group intervention
Number of subjects: 80
Study 31904670 — intervention group
Group type: COMPARATOR
Intervention: Control individual psychoeducational schedule
Number of subjects: 80
Study 30244348 — intervention group
Group type: COMPARATOR
Intervention: Yam peel meal (YPM) at 0% (T1)
Number of subjects: 16
Study 30244348 — intervention group
Group type: EXPERIMENTAL
Intervention: Yam peel meal (YPM) at 50% (T2)
Number of subjects: 16
Study 30244348 — intervention group
Group type: EXPERIMENTAL
Intervention: Yam peel meal (YPM) at 75% (T3)
Number of subjects: 16
Study 30244348 — intervention group
Group type: EXPERIMENTAL
Intervention: Yam peel meal (YPM) at 100% (T4)
Number of subjects: 16
Study 28394171 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful emotion awareness training
Number of subjects: 10
Study 28394171 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 10
Study 28394171 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (mindful emotion awareness training and cognitive reappraisal)
Number of subjects: 10
Study 28394171 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful emotion awareness training and cognitive reappraisal
Number of subjects: 10
Study 25985045 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoanalytic psychotherapy (PPT)
Number of subjects: 0
Study 25985045 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 0
Study 23691822 — intervention group
Group type: EXPERIMENTAL
Intervention: Time constraint present
Number of subjects: 88
Study 23691822 — intervention group
Group type: COMPARATOR
Intervention: No time constraint
Number of subjects: 88
Study 23691822 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple similarly named nontargets present
Number of subjects: 88
Study 23691822 — intervention group
Group type: EXPERIMENTAL
Intervention: Tall Man lettering
Number of subjects: 88
Study 20966820 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical deactivation of migraine headache trigger sites
Number of subjects: 125
Study 20966820 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections to confirm trigger sites followed by surgical deactivation
Number of subjects: 125
Study 20966820 — intervention group
Group type: COMPARATOR
Intervention: Saline injections (control)
Number of subjects: 125
Study 18318728 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential delivery of 595-nm PDL and 1,064-nm Nd:YAG lasers
Number of subjects: 20
Study 18318728 — intervention group
Group type: COMPARATOR
Intervention: 595-nm PDL laser alone
Number of subjects: 20
Study 18318728 — intervention group
Group type: COMPARATOR
Intervention: 1,064-nm Nd:YAG laser alone
Number of subjects: 20
Study 17078221 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexicor
Number of subjects: 20
Study 14604019 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.65 g/kg dose of alcohol
Number of subjects: 25
Study 14604019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 10994825 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cefazolin
Number of subjects: 60
Study 10994825 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 60
Study 10994825 — intervention group
Group type: COMPARATOR
Intervention: Historical controls (not specified as a separate group)
Number of subjects: 60
Study 8797620 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone (50-micrograms/kg loading dose, followed by 0.25 microgram/kg/min continuous infusion)
Number of subjects: 106
Study 8797620 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone (50-micrograms/kg loading dose, followed by 0.5 microgram/kg/min continuous infusion)
Number of subjects: 106
Study 8797620 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone (50-micrograms/kg loading dose, followed by 0.75 microgram/kg/min continuous infusion)
Number of subjects: 106
Study 8797620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 1626173 — intervention group
Group type: EXPERIMENTAL
Intervention: RU486 (600 mg) followed by Nalador (intravenous sulprostone)
Number of subjects: 73
Study 1626173 — intervention group
Group type: COMPARATOR
Intervention: Nalador only
Number of subjects: 73
Study 6385894 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloride titrator strip
Number of subjects: 32
Study 6385894 — intervention group
Group type: COMPARATOR
Intervention: No use of chloride titrator strip (control)
Number of subjects: 32
Study 30674987 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal stimulation of the right dorsolateral prefrontal cortex (dlPFC)
Number of subjects: 100
Study 30674987 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation of the right dorsolateral prefrontal cortex (dlPFC)
Number of subjects: 100
Study 28215130 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous GLP-1 (1.2 pmol/kg/min)
Number of subjects: 12
Study 28215130 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 12
Study 25730614 — intervention group
Group type: EXPERIMENTAL
Intervention: Real stimulation (rTMS)
Number of subjects: 18
Study 25730614 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 18
Study 24357810 — intervention group
Group type: EXPERIMENTAL
Intervention: sifalimumab for 6 months
Number of subjects: 48
Study 24357810 — intervention group
Group type: COMPARATOR
Intervention: placebo for 3 months
Number of subjects: 48
Study 21653628 — intervention group
Group type: EXPERIMENTAL
Intervention: JOBS program
Number of subjects: 0
Study 21653628 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 21653628 — intervention group
Group type: COMPARATOR
Intervention: Voucher intervention
Number of subjects: 0
Study 19122353 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise advice and prescription, dietary instructions
Number of subjects: 217
Study 19122353 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 217
Study 17413096 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 meal/d
Number of subjects: 0
Study 17413096 — intervention group
Group type: COMPARATOR
Intervention: 3 meals/d
Number of subjects: 0
Study 15480049 — intervention group
Group type: EXPERIMENTAL
Intervention: CT scans of patients with MPO-ANCA
Number of subjects: 62
Study 15480049 — intervention group
Group type: EXPERIMENTAL
Intervention: CT findings in patients with MPO-ANCA
Number of subjects: 62
Study 11843382 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate
Number of subjects: 1529
Study 11843382 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel implants
Number of subjects: 1529
Study 11843382 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestogen-only oral contraceptives and progesterone vaginal ring
Number of subjects: 1529
Study 9760010 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubeluzole 2.5 mg, 5 mg, and 10 mg
Number of subjects: 12
Study 9760010 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubeluzole 15 mg, 20 mg, and 25 mg
Number of subjects: 12
Study 9760010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7930388 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) stimulation with arginine (0.5 g/kg bw) and recombinant GH (4 IU im) in Group 2 (normal IGF-I range)
Number of subjects: 39
Study 7930388 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) stimulation with arginine (0.5 g/kg bw) and recombinant GH (4 IU im) in Group 1 (abnormally low IGF-I concentration)
Number of subjects: 39
Study 7930388 — intervention group
Group type: COMPARATOR
Intervention: Arginine-stimulated GH peak values
Number of subjects: 39
Study 3062957 — intervention group
Group type: COMPARATOR
Intervention: SSI 70
Number of subjects: 7
Study 3062957 — intervention group
Group type: EXPERIMENTAL
Intervention: Activitrax
Number of subjects: 7
Study 3062957 — intervention group
Group type: EXPERIMENTAL
Intervention: Nova MR
Number of subjects: 7
Study 31936519 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese propolis paste as an intracanal medicament
Number of subjects: 80
Study 31936519 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide (control)
Number of subjects: 80
Study 29372626 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine/cisplatin (XP)
Number of subjects: 126
Study 29372626 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil/cisplatin (FP)
Number of subjects: 126
Study 26682955 — intervention group
Group type: EXPERIMENTAL
Intervention: ST2‐R2 score strata (score 9-11)
Number of subjects: 569
Study 26682955 — intervention group
Group type: EXPERIMENTAL
Intervention: ST2‐R2 score strata (score 12-14)
Number of subjects: 569
Study 26682955 — intervention group
Group type: EXPERIMENTAL
Intervention: ST2‐R2 score strata (score 15-17)
Number of subjects: 569
Study 26682955 — intervention group
Group type: EXPERIMENTAL
Intervention: ST2‐R2 score
Number of subjects: 569
Study 25428209 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of vascular risk factors (physician-managed with biannual monitoring)
Number of subjects: 2210
Study 23439168 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise self-titration of oral glucose-lowering medication with self-monitoring and remote nurse monitoring
Number of subjects: 14
Study 23439168 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 14
Study 23439168 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group patients changing their oral glucose-lowering medication
Number of subjects: 14
Study 23439168 — intervention group
Group type: COMPARATOR
Intervention: Control group patients changing their oral glucose-lowering medication
Number of subjects: 14
Study 20528837 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg thiamylal
Number of subjects: 50
Study 20528837 — intervention group
Group type: COMPARATOR
Intervention: 1.5 mg/kg propofol
Number of subjects: 50
Study 17562958 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramyocardial injection of autologous CD34+ stem cells
Number of subjects: 24
Study 17562958 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 24
Study 15486408 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitaxsentan (100 mg/d)
Number of subjects: 11
Study 11712824 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 19
Study 11712824 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 19
Study 11712824 — intervention group
Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 19
Study 9547423 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reward instructions and materials delivered at the end of the BSE training session
Number of subjects: 1649
Study 9547423 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reward suggestions delivered through the mail each month, contingent upon BSE performance
Number of subjects: 1649
Study 9547423 — intervention group
Group type: EXPERIMENTAL
Intervention: External monetary rewards and self-reward suggestions delivered through the mail each month on an intermittent schedule, contingent upon BSE practice
Number of subjects: 1649
Study 9547423 — intervention group
Group type: COMPARATOR
Intervention: No-reward control condition
Number of subjects: 1649
Study 8042812 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal classification (OP class) assessment with various method combinations (sitting, head in extension, tongue out, with/without phonation)
Number of subjects: 213
Study 8042812 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular space (MS) length measurement with various method combinations (sitting, head in extension, distance from inside of mentum to thyroid cartilage)
Number of subjects: 213
Study 8042812 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined performance index of OP class and MS length
Number of subjects: 213
Study 3195433 — intervention group
Group type: EXPERIMENTAL
Intervention: History of cigarette smoking within 6 months
Number of subjects: 328
Study 3195433 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from onset of symptoms to peak CK‐MB value
Number of subjects: 328
Study 3195433 — intervention group
Group type: EXPERIMENTAL
Intervention: Congestive heart failure during or after hospitalization
Number of subjects: 328
Study 3195433 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality during hospitalization or follow-up
Number of subjects: 328
Study 3195433 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejection fractions on radionuclide ventriculography at 10 days and 3 months after AMI
Number of subjects: 328
Study 30041587 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutual-access EHRs
Number of subjects: 141
Study 30041587 — intervention group
Group type: COMPARATOR
Intervention: No mutual-access EHRs
Number of subjects: 141
Study 30041587 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall communication
Number of subjects: 141
Study 30041587 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health hospitalizations and emergency department visits
Number of subjects: 141
Study 30041587 — intervention group
Group type: EXPERIMENTAL
Intervention: Medications acknowledged in PCP record
Number of subjects: 141
Study 26643401 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBEX (community-based exercise program)
Number of subjects: 34
Study 26643401 — intervention group
Group type: COMPARATOR
Intervention: EX (outpatient exercise program at the hospital)
Number of subjects: 34
Study 25899562 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-PDT + CO2 laser
Number of subjects: 18
Study 25899562 — intervention group
Group type: COMPARATOR
Intervention: CO2 laser alone
Number of subjects: 18
Study 23824974 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 0
Study 21126127 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg plus low dose aspirin (LDA), n = 30
Number of subjects: 60
Study 21126127 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 20 mg plus LDA, n = 30
Number of subjects: 60
Study 18565233 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate 400 mg once a day
Number of subjects: 3011
Study 18565233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3011
Study 16497101 — intervention group
Group type: EXPERIMENTAL
Intervention: Goeckerman's therapy (GT) including dermal application of crude coal tar and exposure to UV radiation
Number of subjects: 56
Study 16497101 — intervention group
Group type: EXPERIMENTAL
Intervention: Goeckerman's therapy (GT)
Number of subjects: 56
Study 16497101 — intervention group
Group type: COMPARATOR
Intervention: Patients before GT
Number of subjects: 56
Study 14571257 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral D-amphetamine (AMPH) 30 mg
Number of subjects: 34
Study 14571257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 11483804 — intervention group
Group type: EXPERIMENTAL
Intervention: AeroChamber mask
Number of subjects: 30
Study 11483804 — intervention group
Group type: EXPERIMENTAL
Intervention: Hans Rudolph mask
Number of subjects: 30
Study 11483804 — intervention group
Group type: EXPERIMENTAL
Intervention: NebuChamber mask
Number of subjects: 30
Study 11483804 — intervention group
Group type: EXPERIMENTAL
Intervention: BabyHaler mask
Number of subjects: 30
Study 11483804 — intervention group
Group type: COMPARATOR
Intervention: Uncoached session
Number of subjects: 30
Study 11483804 — intervention group
Group type: EXPERIMENTAL
Intervention: Coached session
Number of subjects: 30
Study 9894373 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg sildenafil (adjustable to 100 mg or 25 mg based on efficacy and tolerability)
Number of subjects: 329
Study 9894373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 329
Study 9894373 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg sildenafil
Number of subjects: 329
Study 8114658 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo care (KC) for 2 to 3 hours
Number of subjects: 31
Study 8114658 — intervention group
Group type: COMPARATOR
Intervention: Control group (pretest/posttest design)
Number of subjects: 31
Study 3281463 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotetan 1 to 2 gm every 12 hours
Number of subjects: 188
Study 3281463 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin 1 to 2 gm every 6 hours
Number of subjects: 188
Study 3281463 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotetan
Number of subjects: 188
Study 3281463 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 188
Study 30083968 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Broström procedure with calcaneofibular ligament (CFL) repair
Number of subjects: 50
Study 30083968 — intervention group
Group type: COMPARATOR
Intervention: Modified Broström procedure without CFL repair (ATFL only group)
Number of subjects: 50
Study 30083968 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CFL and ATFL only)
Number of subjects: 50
Study 30083968 — intervention group
Group type: EXPERIMENTAL
Intervention: CFL repair
Number of subjects: 50
Study 31290573 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreserved PLTs
Number of subjects: 121
Study 31290573 — intervention group
Group type: COMPARATOR
Intervention: Liquid-stored PLTs
Number of subjects: 121
Study 31290573 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 121
Study 28542176 — intervention group
Group type: COMPARATOR
Intervention: DHS-style survey variant (little contextual detail about the wife's intentions)
Number of subjects: 1334
Study 28542176 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey variant depicting the wife as intentionally violating gendered standards of behavior
Number of subjects: 1334
Study 28542176 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey variant depicting the wife as unintentionally violating gendered standards of behavior
Number of subjects: 1334
Study 28542176 — intervention group
Group type: COMPARATOR
Intervention: DHS-style survey variant (control)
Number of subjects: 1334
Study 25431336 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolofylline
Number of subjects: 2033
Study 25431336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2033
Study 22495503 — intervention group
Group type: EXPERIMENTAL
Intervention: WebChoice
Number of subjects: 325
Study 22495503 — intervention group
Group type: COMPARATOR
Intervention: Control group (URLs of publicly available cancer websites)
Number of subjects: 325
Study 22211208 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention featuring actors simulating a patient discussing treatment concerns (N=24)
Number of subjects: 50
Study 22211208 — intervention group
Group type: COMPARATOR
Intervention: Control group shown an educational video about schizophrenia treatment (N=26)
Number of subjects: 50
Study 19921623 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam (CLB)
Number of subjects: 38
Study 19921623 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 38
Study 16802845 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (SMART)
Number of subjects: 2143
Study 16802845 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol/fluticasone (SFC)
Number of subjects: 2143
Study 12539209 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalamic deep brain stimulation (DBS)
Number of subjects: 39